Overview
- 4 inspections across 3 sites are on record.
- 8 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-21.
At a glance
Inspections
4
Sites
3
Observations
8
Career since
Nov 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Kedrion Biopharma Inc. | 21 May 2026 | Biologics | View 483 → |
| Biotest Ag | 15 Dec 2023 | Biologics | On file |
| Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 16 Apr 2019 | Biologics | On file |
| Kedrion Biopharma Inc. | 16 Nov 2018 | Biologics | On file |
Sites inspected
Kedrion Biopharma Inc.Melville, United States2 insp.
Biotest AgDreieich, Germany1 insp.
Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.Vienna, Austria1 insp.
Co-investigators
Investigators who share inspections with this person.
Malgorzata G Norton2 shared
Scott T Ballard1 shared
Neetu Dahiya1 shared
Miriam M Ngundi1 shared
Nicole M Li1 shared
Debra M Emerson1 shared
Olga Simakova1 shared
Joan Johnson1 shared
Bradley J Dworak1 shared
Irina Gaberman1 shared
Full investigator report
Get the verbatim findings behind Lu Deng's 8 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site